Postes actifs de Armend G. Håti
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Nordovo Biosciences AS
 Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Directeur Général | 01/01/2020 | - |
| Fondateur | - | - |
Historique de carrière de Armend G. Håti
Statistiques
Internationale
| Norvège | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Nordovo Biosciences AS
Nordovo Biosciences AS BiotechnologyHealth Technology Nordovo Biosciences AS, operating under the name clexbio, is a pre-clinical stage biotech company based in Oslo, Norway. The Norwegian company is focused on developing next-generation tissue-engineered allogeneic grafts for transplant, using its proprietary platform technologies clex and vivoset. clexbio combines advanced bio-fabrication approaches with its proprietary hydrogel technology clex to create breakthrough solutions for tissue engineering and single-cell techniques. The private company was founded by Manuel Schweikle and Armend G. Håti, with Armend G. Håti serving as CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Armend G. Håti
- Expérience
